Research programme: chitosan-encapsulated biological molecules - Advancell

Drug Profile

Research programme: chitosan-encapsulated biological molecules - Advancell

Alternative Names: ADVP 1; ADVP 2; ADVP 3; ADVP 4; ADVP 5; ADVP 6; ATH 003; ATH 006; ATH 007

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AdvanCell
  • Class Peptide hormones; Polysaccharides
  • Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Diabetes mellitus; Thrombosis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in Spain (PO)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Thrombosis in Spain (PO)
  • 20 Apr 2012 Early research in Diabetes mellitus & Thrombosis is ongoing in Spain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top